BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37040756)

  • 1. Low clinical sensitivity and unexpectedly high incidence for neuropathologically diagnosed progressive supranuclear palsy.
    Driver-Dunckley ED; Zhang N; Serrano GE; Dunckley NA; Sue LI; Shill HA; Mehta SH; Belden C; Tremblay C; Atri A; Adler CH; Beach TG
    J Neuropathol Exp Neurol; 2023 Apr; 82(5):438-451. PubMed ID: 37040756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of the National Institute for Neurological Disorders and Stroke/Society for Progressive Supranuclear Palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy.
    Respondek G; Roeber S; Kretzschmar H; Troakes C; Al-Sarraj S; Gelpi E; Gaig C; Chiu WZ; van Swieten JC; Oertel WH; Höglinger GU
    Mov Disord; 2013 Apr; 28(4):504-9. PubMed ID: 23436751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy.
    Ali F; Martin PR; Botha H; Ahlskog JE; Bower JH; Masumoto JY; Maraganore D; Hassan A; Eggers S; Boeve BF; Knopman DS; Drubach D; Petersen RC; Dunkley ED; van Gerpen J; Uitti R; Whitwell JL; Dickson DW; Josephs KA
    Mov Disord; 2019 Aug; 34(8):1144-1153. PubMed ID: 30726566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation.
    Stejskalova Z; Rohan Z; Rusina R; Tesar A; Kukal J; Kovacs GG; Bartos A; Matej R
    BMC Neurol; 2019 Mar; 19(1):42. PubMed ID: 30894142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rainwater Charitable Foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy.
    Roemer SF; Grinberg LT; Crary JF; Seeley WW; McKee AC; Kovacs GG; Beach TG; Duyckaerts C; Ferrer IA; Gelpi E; Lee EB; Revesz T; White CL; Yoshida M; Pereira FL; Whitney K; Ghayal NB; Dickson DW
    Acta Neuropathol; 2022 Oct; 144(4):603-614. PubMed ID: 35947184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial aggregation of parkinsonism in progressive supranuclear palsy.
    Donker Kaat L; Boon AJ; Azmani A; Kamphorst W; Breteler MM; Anar B; Heutink P; van Swieten JC
    Neurology; 2009 Jul; 73(2):98-105. PubMed ID: 19458322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome.
    Williams DR; Holton JL; Strand C; Pittman A; de Silva R; Lees AJ; Revesz T
    Brain; 2007 Jun; 130(Pt 6):1566-76. PubMed ID: 17525140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Stage of Progressive Supranuclear Palsy: A Neuropathological Study of 324 Consecutive Autopsy Cases.
    Nogami A; Yamazaki M; Saito Y; Hatsuta H; Sakiyama Y; Takao M; Kimura K; Murayama S
    J Nippon Med Sch; 2015; 82(6):266-73. PubMed ID: 26823029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incipient progressive supranuclear palsy is more common than expected and may comprise clinicopathological subtypes: a forensic autopsy series.
    Yoshida K; Hata Y; Kinoshita K; Takashima S; Tanaka K; Nishida N
    Acta Neuropathol; 2017 May; 133(5):809-823. PubMed ID: 28064358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological features of progressive supranuclear palsy with asymmetrical atrophy of the superior cerebellar peduncle.
    Koizumi R; Akagi A; Riku Y; Sone J; Miyahara H; Tanaka F; Yoshida M; Iwasaki Y
    Neuropathology; 2023 Jun; 43(3):233-243. PubMed ID: 36222051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progressive supranuclear palsy; an unusual form of parkinsonism].
    Donker Kaat L; Boon AJ; Heutink P; van Swieten JC
    Ned Tijdschr Geneeskd; 2004 Mar; 148(11):519-23. PubMed ID: 15054950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which ante mortem clinical features predict progressive supranuclear palsy pathology?
    Respondek G; Kurz C; Arzberger T; Compta Y; Englund E; Ferguson LW; Gelpi E; Giese A; Irwin DJ; Meissner WG; Nilsson C; Pantelyat A; Rajput A; van Swieten JC; Troakes C; Josephs KA; Lang AE; Mollenhauer B; Müller U; Whitwell JL; Antonini A; Bhatia KP; Bordelon Y; Corvol JC; Colosimo C; Dodel R; Grossman M; Kassubek J; Krismer F; Levin J; Lorenzl S; Morris H; Nestor P; Oertel WH; Rabinovici GD; Rowe JB; van Eimeren T; Wenning GK; Boxer A; Golbe LI; Litvan I; Stamelou M; Höglinger GU;
    Mov Disord; 2017 Jul; 32(7):995-1005. PubMed ID: 28500752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic discrepancies in a population-based incidence study of parkinsonism in olmsted county: 1991-2010.
    Turcano P; Mielke MM; Josephs KA; Bower JH; Parisi JE; Boeve BF; Savica R
    Mov Disord; 2017 Oct; 32(10):1439-1446. PubMed ID: 28843020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and Trends of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Population-Based Study.
    Stang CD; Turcano P; Mielke MM; Josephs KA; Bower JH; Ahlskog JE; Boeve BF; Martin PR; Upadhyaya SG; Savica R
    J Parkinsons Dis; 2020; 10(1):179-184. PubMed ID: 31594251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of clinical diagnosis of progressive supranuclear palsy.
    Osaki Y; Ben-Shlomo Y; Lees AJ; Daniel SE; Colosimo C; Wenning G; Quinn N
    Mov Disord; 2004 Feb; 19(2):181-9. PubMed ID: 14978673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Parkinson's disease" on the way to progressive supranuclear palsy: a review on PSP-parkinsonism.
    Necpál J; Borsek M; Jeleňová B
    Neurol Sci; 2021 Dec; 42(12):4927-4936. PubMed ID: 34532773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy.
    Caparros-Lefebvre D; Sergeant N; Lees A; Camuzat A; Daniel S; Lannuzel A; Brice A; Tolosa E; Delacourte A; Duyckaerts C
    Brain; 2002 Apr; 125(Pt 4):801-11. PubMed ID: 11912113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy.
    Sakae N; Josephs KA; Litvan I; Murray ME; Duara R; Uitti RJ; Wszolek ZK; Graff-Radford NR; Dickson DW
    Mov Disord; 2019 Nov; 34(11):1655-1662. PubMed ID: 31433871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olfaction in Neuropathologically Defined Progressive Supranuclear Palsy.
    Shill HA; Zhang N; Driver-Dunckley E; Mehta S; Adler CH; Beach TG
    Mov Disord; 2021 Jul; 36(7):1700-1704. PubMed ID: 33755262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progressive supranuclear palsy].
    Hasegawa K
    Rinsho Shinkeigaku; 1997 Dec; 37(12):1128-30. PubMed ID: 9577667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.